OCULAR THERAPEUTIX, INC
Biopharmaceutical company developing sustained-release therapies for eye diseases.
OCUL | US
Overview
Corporate Details
- ISIN(s):
- US67576A1007
- LEI:
- Country:
- United States of America
- Address:
- 15 CROSBY DRIVE, 1730 BEDFORD
- Website:
- https://www.ocutx.com/
- Sector:
- Manufacturing
Description
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company's primary focus is on transforming the treatment of retinal diseases, such as wet age-related macular degeneration (wet AMD), a leading cause of blindness. Ocular Therapeutix utilizes its proprietary hydrogel-based drug delivery platform, ELUTYX™, to develop sustained-release therapies. This technology is designed to reduce the therapeutic burden on patients by decreasing the frequency of required treatments. The company's lead product candidate, AXPAXLI™ (axitinib intravitreal implant), is in late-stage clinical development for major retinal diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 13:25 |
10-Q - OCULAR THERAPEUTIX, INC (0001393434) (Filer)
|
English | 1.5 MB | ||
| 2025-11-04 13:19 |
8-K - OCULAR THERAPEUTIX, INC (0001393434) (Filer)
|
English | 177.7 KB |
Automate Your Workflow. Get a real-time feed of all OCULAR THERAPEUTIX, INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OCULAR THERAPEUTIX, INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OCULAR THERAPEUTIX, INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
